Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The smaller market now envisioned for vepdegestrant has changed both companies’ stance on their original deal, leading to negotiations that could either lead to a new alliance or Arvinas to seek a new ...

Recent health news highlights include Kenvue cutting its sales forecast amid strategic changes, Eli Lilly raising its profit ...

In early corporate news, GSK wins a payout after settlement is reached in the legal action between partner CureVac and BioNTech on Thursday, while Renewables Infrastructure posts a widened interim ...

Tokyo, Japan and Cambridge, UK, 8 August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second ...

Oil and gas markets weaken as OPEC output expectations and trade tensions cap gains. Key support and resistance levels guide ...

Dow Jones Top Company Headlines at 5 AM ET: Intel's CEO, Under Attack From Trump, Is Already at Odds With His Board | Apple ... Lip-Bu Tan and the chip maker's directors have been clashing over how to ...

NASDAQ tested new highs, supported by the strong performance of Apple stock. Shopify, which gained 21.2%, was the biggest ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Pfizer Inc. (NYSE: PFE) delivered a stronger-than-anticipated second-quarter performance, beating analyst estimates and ...

The government is in talks with pharmaceutical companies to raise the prices of certain medications outside the U.S.